These companies typically maintain steady income streams regardless of economic downturns, as government spending on law enforcement and corrections tends to remain consistent even during challenging financial times.
Current political discourse around border security and law enforcement practices is driving increased government contracts and investments in new monitoring technologies and security infrastructure.
Several companies in this collection are at the forefront of developing non-lethal weapons, AI-powered surveillance, and advanced security systems that are transforming how public safety is maintained.
These companies operate at the intersection of public safety and private enterprise. Their business models rely on non-discretionary, government-funded spending for law enforcement, correctional facilities, and security technology, offering potential stability regardless of economic conditions.
Unlike consumer-dependent industries, these stocks derive revenue primarily from government contracts and public safety budgets. This collection includes private prison operators, manufacturers of enforcement technology, and providers of security services essential to public infrastructure.
We've selected market leaders in for-profit incarceration alongside innovators in surveillance technology and non-lethal weaponry. Each company holds a strategic position within government security frameworks, potentially benefiting from increased public spending on border security and law enforcement technologies.
This carefully selected portfolio focuses on companies operating in public safety and corrections. These stocks represent firms with steady, government-backed revenue streams that tend to perform independently of broader economic trends.
Aggregate market capitalisation and breakdown for the 'Prison & Enforcement' basket.
CXW: $1.96B
GEO: $2.47B
AXON: $55.51B
Erfahren Sie alles über diesen Aktienkorb. Lesen Sie unseren ausführlichen Artikel zu seinen Risiken und seinem Potenzial.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
+5
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
Wenn Sie in diese Werte investieren:
In 12 Monaten könnte der Wert betragen:
+250.19%
Analysten erwarten im Durchschnitt, dass die Werte dieser Gruppe im nächsten Jahr um 250.19 % zulegen.
14 von 15 Werten dieser Gruppe werden von professionellen Analysten mit „Kaufen“ bewertet.
